髓内脊髓肿瘤切除术后远期后索功能障碍的预测因素:比较病例系列
该病例对照研究纳入37例髓内脊髓肿瘤切除术患者,比较后索分离保留技术与中线电凝切开技术,发现前者在MMS、SF-36和DCQ评分上均更优,且术中SSEP丢失发生率更低,髓切开技术和术中SSEP消失是远期功能障碍和后索功能障碍的主要决定因素。
要点
- 后索分离保留髓切开技术可降低远期后索功能障碍和术中SSEP丢失。
- 髓切开技术和术中SSEP消失是远期残疾和后索功能障碍的主要决定因素。
- 术后DCD在IMSCT手术患者中发生率为43.6%-55.1%。
核心结论
- 后索分离保留髓切开技术相比中线电凝切开技术,与更低的远期后索功能障碍、术中SSEP丢失及更好的健康相关生活质量和残疾评分相关。
- 髓切开技术和术中SSEP消失(即使短暂)是远期残疾和后索功能障碍的主要决定因素。
研究设计与样本
- 病例对照研究,纳入连续患者37例,按中线髓切开技术分为后索分离保留组(A组)和中线电凝切开组(B组)。
- 采用SF-36、McCormick量表(MMS)、Douleur Neuropathique 4 Questions及三领域数字评定量表(后索问卷DCQ)进行评估。
- 术中神经电生理监测(IONM)记录三个时间点:术中基线、术中 worst、术中最终。
主要发现
- A组在末次随访时MMS(p=0.002)、SF-36(p=0.001)和DCQ(p=0.031)评分均优于B组。
- B组术中 worst(p=0.002)和术中最终(p=0.026)SSEP丢失发生率显著更高。
- DCQ的单因素分析显示主要预后因素包括:髓切开技术(p=0.012)、毛细血管瘤组织学(p=0.045)和术中 worst SSEP(p=0.034)。
- MMS的单因素分析显示主要预后因素包括:髓切开技术(p<0.001)、术中SSEP(p<0.001)、术中最终SSEP(p<0.001)和随访时肠道膀胱功能障碍(p=0.02)。
- 术中最终SSEP不在DCQ预后因素中(p=0.213)。
关键数值与推荐
- 术后DCD在IMSCT手术患者中发生率为43.6%-55.1%。
- A组与B组人口学参数无显著差异。
临床怎么用
- 在髓内脊髓肿瘤切除中,优先采用后索分离保留髓切开技术以减少远期后索功能障碍。
- 术中SSEP消失(即使短暂)应被视为远期残疾和后索功能障碍的重要预警信号。
局限性
- 样本量较小(37例),可能限制统计效能和结论外推。
- 为病例对照研究设计,可能存在选择偏倚和混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Postoperative dorsal column dysfunction (DCD) has been observed in 43.6%-55.1% of patients who have undergone surgery for intramedullary spinal cord tumors (IMSCTs). There is a paucity of evidence regarding the prognosticators of its occurrence. The objective of the present study was to ascertain the prognostic factors associated with long-term DCD following IMSCT resection, with a particular emphasis on the role of the myelotomy technique and intraoperative neuromonitoring (IONM). METHODS: A case-control study was conducted on consecutive patients. Patients were stratified based on the surgical technique used for midline myelotomy: dorsal column (DC) dissection and preservation technique (group A) and midline coagulation and incision technique (group B). Somatosensory evoked potentials (SSEPs) were categorized as either present or absent. The groups were then analyzed with respect to the Short Form Health Survey 36 (SF-36), the McCormick Scale (MMS), Douleur Neuropathique 4 Questions, and a 3-domain numeric rating scale for investigating DCD, named the Dorsal-Columns Questionnaire (DCQ). Univariate analyses were conducted for MMS and DCQ scores, with data regarding demographics; neurological examination; symptoms; surgery, including extent of resection, tumor histology, tumor location, myelotomy, and tumor extension; hemosiderin cap, cleavage plane presence; and IONM taken into consideration. IONM was recorded at three time points during the surgical procedure: baseline intraoperative, worst intraoperative, and final intraoperative. RESULTS: In total, 37 patients were included. Groups A and B had nonsignificantly different demographic parameters. Group A had superior outcomes in MMS (p = 0.002), SF-36 (p = 0.001), and DCQ (p = 0.031) scores at the last follow-up. Group B experienced a significantly higher incidence of worst intraoperative (p = 0.002) and final intraoperative (p = 0.026) SSEP loss. Univariate analysis documented the following major prognostic factors: myelotomy technique (p = 0.012), capillary hemangioma histology (p = 0.045), and worst intraoperative SSEPs (p = 0.034) for the DCQ; myelotomy technique (p < 0.001), intraoperative (p < 0.001) and final intraoperative (p < 0.001) SSEPs, and follow-up bowel-bladder dysfunction (p = 0.02) for the MMS. Final operative SSEPs were not among DCQ prognosticators (p = 0.213). CONCLUSIONS: The DC dissection and preservation myelotomy technique is associated with lower long-term DCD and intraoperative SSEP loss and better health-related quality of life and disability when compared with the midline coagulation and incision technique. The myelotomy technique and intraoperative SSEP disappearance, even if transient, are major determinants of long-term disability and DCDs.
引用
- Polli FM, Battistelli M, Rapisarda A, et al. Predictive factors of long-term dorsal column dysfunction after intramedullary spinal cord tumor resection: a comparative case series. J Neurosurg Spine. 2026. PMID: 41569650. doi:10.3171/2025.9.SPINE25671
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。